alert icon Coronavirus

Think you may have COVID-19?
Find out where you can get tested

Need a vaccine or booster?
Schedule today

Coming to a Cleveland Clinic location?
Visitation and mask requirements

Department Cardiovascular Medicine
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon No
Locations Specialties & Treatments

Treatment & Services

  • Abnormal Stress Test
  • Angiography
  • Angioplasty
  • Atherectomy
  • Cardiovascular Medicine
  • Cardiovascular Medicine Department
  • Clinical Trials
  • Coronary Balloon Angioplasty (PTCA)
  • Coronary Intervention
  • Drug Eluting Stenting
  • FFR determination
  • Intervention Section
  • Interventional Cardiology
  • Intra-aortic Balloon Pumping
  • Invasive & Interventional Cardiology Section
  • Invasive Cardiology
  • Invasive Cardiology Section
  • Rotational Atherectomy
  • Virtual Histology
View all 19 Treatment & Services +

Specialty in Diseases & Conditions

  • Angina
  • Bifurcation Blockage
  • Coronary Artery Disease
  • Heart Attack
  • Ischemic Cardiomyopathy
  • Restenosis
View all 6 Specialties +
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About A. Michael Lincoff, MD

A. Michael Lincoff, MD, is Vice Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine and an interventional cardiologist in the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute at Cleveland Clinic.

He supervises clinical research activities throughout the Cleveland Clinic as Director of the Center for Clinical Research of the Lerner Research Institute. Dr. Lincoff is also the Director of the Cleveland Clinic Coordinating Center for Clinical Research (C5Research), an academic research organization that plans, coordinates and manages multicenter clinical trials of new pharmacologic or device therapies.

Dr. Lincoff’s research activities focus on development of therapies to reduce acute and long-term complications of percutaneous coronary revascularization procedures, to optimize therapy for acute coronary ischemic syndromes or reduce progression or complications of atherosclerosis. He has served as principal investigator or steering committee member of over 15 pivotal trials in ischemic heart disease, enrolling in aggregate over 50,000 patients, studying new antiplatelet or antithrombotic agents in the settings of coronary intervention, heart attack or unstable angina.

Dr. Lincoff is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He holds the Charles and Charlotte Fowler Endowed Chair for Cardiovascular Research at Cleveland Clinic.

Dr. Lincoff has authored or coauthored over 200 peer-reviewed articles, including publications in the New England Journal of Medicine, Journal of the American Medical Association, Lancet, Annals of Internal Medicine, Circulation, Journal of the American College of Cardiology, American Heart Journal and European Heart Journal. He is editor of a book entitled Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease, now in its second edition. He has also authored over 80 book chapters and reviews and presented over 300 lectures at various medical meetings and courses throughout the world. He is the Consulting Editor of the American Journal of Cardiovascular Drugs and serves on editorial boards or as a reviewer for over 15 peer-reviewed scientific journals.

Dr. Lincoff is currently chairman of the Cardiovascular and Renal Drugs Advisory Committee of the United States Food and Drug Administration.

Dr. Lincoff is a fellow of the American College of Cardiology and the European Society of Cardiology and a member of the American College of Physicians, scientific councils of the American Heart Association and the Sigma Xi Scientific Research Society.

Education & Professional Highlights

Education & Professional Highlights

Appointed
1994

Education & Fellowships

Fellowship - Cleveland Clinic
Interventional Cardiology
Cleveland, OH USA
1993

Fellowship - Cleveland Clinic
Cardiovascular Disease
Cleveland, OH USA
1992

Fellowship - University of Michigan Health System
Cardiovascular Medicine
Ann Arbor, MI USA
1991

Residency - Beth Israel Deaconess Medical Center and Harvard Medical School
Internal Medicine
Boston, MA USA
1989

Internship - Beth Israel Deaconess Medical Center and Harvard Medical School
Medical Internship
Boston, MA USA
1987

Medical Education - Johns Hopkins University School of Medicine
Baltimore, MD USA
1986

Undergraduate - Carnegie Mellon University
Chemical/Biomed. Engineering
Pittsburgh, PA USA
1982

Professional Highlights

  • Director, Center for Clinical Research and Vice Chairman for Clinical Research of the Cleveland Clinic Lerner Research Institute
  • Director, Cleveland Clinic Coordinating Center for Clinical Research (C5Research)
  • Vice Chairman, Department of Cardiovascular Medicine, Cleveland Clinic
  • Charles and Charlotte Fowler Endowed Chair in Cardiovascular Research, Cleveland Clinic

Certifications

  • Internal Medicine
  • Internal Medicine - Interventional Cardiology
  • Internal Medicine - Cardiovascular Disease

Specialty Interests

Coronary artery disease, heart attack, stent restenosis, total coronary occlusions, angioplasty, rotational atherectomy, stent-coronary, coronary artery atherectomy, coronary intervention, drug eluting stenting

Awards & Honors

  • Best Doctors, Cleveland magazine

Memberships

  • American College of Cardiology
  • European Society of Cardiology
  • American College of Physicians
  • American Heart Association
  • Sigma Xi Research Society
Research & Publications

Research & Publications

See publications for A. Michael Lincoff, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 3/10/2022, Dr. Lincoff has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Lincoff receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Novo Nordisk, A/S
  • Becton, Dickinson and Company
  • Akebia Therapeutics, Inc.
  • Provention Bio, Inc.
  • Endologix
  • FibroGen, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Patient Satisfaction Reviews

157 Patient Satisfaction Reviews

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.

Overall Star Ratings
4.9 out of 5
Explains 4.9
Listens 5
Courtesy, Respect & Concern 4.9
Patient Rating of Doctor 4.9

19 Patient Comments

Reviewed on Feb 21, 2022

I have been a patient for a long time and I have recommended Dr. Linncoff on many occasions.

Reviewed on Jan 21, 2022

Dr. Lincoff is a superb provider, always listening, always concerned about my overall health

Reviewed on Jan 17, 2022

Dr Lincoff was very professional during our appt, showed compassion, explained my diagnosis, and took the time to show me my cardiac catheterization on his computer.

Reviewed on Jan 14, 2022

Dr. Lincoff let us face time my daughter in law who has medical experience. She was able to help with questions on things I didn't understand.

Reviewed on Jan 7, 2022

Very satisfied, doctor was excellent in explaining my problem for the visit.

Reviewed on Jan 3, 2022

Dr Lincoff is very caring

Reviewed on Nov 29, 2021

It was nice to have a short wait to see a physician and everyone was very helpful.

Reviewed on Oct 25, 2021

Provider was very knowledgeable and professional.

Reviewed on Oct 18, 2021

Dr. Lincoff is the best!

Reviewed on Sep 24, 2021

He is a very nice ,Intelligent, Caring physician.

Reviewed on Sep 20, 2021

Excellent doctor need more like him

Reviewed on Sep 17, 2021

Dr. Lincoff the best

Reviewed on Sep 3, 2021

I was very pleased with my previous doctor before his retirement and I am equally pleased with Dr Lincoff

Reviewed on Jul 23, 2021

Dr Lincoff has always kept me informed and gives me advice to help in my particular situation. His demeanor and personality are top notch. I always talk highly of him to my sphere of influence.

Reviewed on Jul 19, 2021

The day after my procedure Dr Goyal came to my room and one of the first things he said was that what he did (stent procedure) was only "patchwork" and that I had clogged arteries all over my body. I did not really understand his point and was so taken aback I did not ask. I think he may have been trying to tell me I needed significant eating behavior modification but he really did not address it. I plan to talk more with Dr Lincoff about it when we can schedule a call. I am deeply appreciative of what Drs Lincoff and Goyal were able to do for me. I don't think my local doctors would have been able to do what they did. The interaction with Dr Goyal was the only negative experience I had in the time I was there-but maybe that is as much on me as I feel as if I should have pressed him more to explain what he meant.

Reviewed on Jun 29, 2021

Mike Lincoff is an excellent physician. I am not the only member of my family to be seen by him and he is thoughtful, caring, and knowledgeable. He is a major asset to CCF.

Reviewed on Jun 23, 2021

Great doctors!

Reviewed on Jun 14, 2021

It is great to have a doctor who does things right!

Reviewed on Jun 4, 2021

Some of these questions didn't really apply to this visit but Dr. Lincoff is the pinnacle of professionalism, expertise, and empathy. He listens, gives expert advice, and cares about his patients.

Back to Top